TheEdgeResearch
Home / Stocks / NUGS

Cannabis Strategic Ventures (NUGS)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$147,372
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-31.42
52-Wk Range
0.0001-0.005
CEO
Simon Yu
Country
US
Currency
USD

Cannabis Strategic Ventures operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $147,372. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -87.3%. Its beta of -31.42 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.01
Price / Book
-0.01
EV / EBITDA
-2.45
Gross margin
9.4%
Operating margin
-73.3%
Net margin
-87.3%
Return on equity
Debt / equity
-1.56
Current ratio
0.12
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
30
IPO date
2009-07-24
Headquarters
Los Angeles, CA, US
About Cannabis Strategic Ventures

Cannabis Strategic Ventures specializes in cultivating cannabis products across the United States. Beyond its growing operations, the firm actively fosters new ventures, expands existing operations, and forms strategic alliances within the broader cannabis ecosystem and its supporting sectors. Its corporate headquarters are situated in Los Angeles, California.

Comparable companies

Cannabis Strategic Ventures is most often compared with the following Healthcare names:

AOLSCBGIFIORFHCANFHSMDLOWLFMPXOFMRRCFPTLFSPLM
More research on NUGS
NUGS technical analysis NUGS TheEdge Score Compare against peers
Open full interactive analysis & DCF →